Stony Brook Eastern Long Island Hosp Behavioral Heath Services
-
Services:
- State government
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- In-network prescribing entity
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Substance use disorder education
- Hepatitis education, counseling, or support
- Individual counseling
- Marital/couples counseling
- HIV or AIDS education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Group counseling
- Mental health services
- Early intervention for HIV
- Suicide prevention services
- Adult men
- Adult women
- Clients with co-occurring mental and substance use disorders
- Vaping not permitted
- Aftercare/continuing care
- Outcome follow-up after discharge
- Naloxone and overdose education
- Discharge Planning
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Buprenorphine maintenance
- Accepts clients using MAT but prescribed elsewhere
- Lofexidine or Clonidine detoxification
- Prescribes buprenorphine
- Buprenorphine detoxification
- Medicare
- Cash or self-payment
- State-financed health insurance plan other than Medicaid
- Medicaid
- Private health insurance
- IHS/Tribal/Urban (ITU) funds
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Male
- Female
- General Hospital (including VA hospital)
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Screening for substance use
- Screening for mental disorders
- Screening for tobacco use
- Sign language services for the deaf and hard of hearing
- This facility administers/prescribes medication for alcohol use disorder
- STD testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis B (HBV)
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- Testing for Hepatitis C (HCV)
- HIV testing
- TB screening
- 12-step facilitation
- Anger management
- Trauma-related counseling
- Cognitive behavioral therapy
- Motivational interviewing
- Substance use disorder counseling
- Relapse prevention
- Brief intervention
- Naltrexone (oral)
- Acamprosate (Campral®)
- Medication for mental disorders
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Medications for Hepatitis C treatment
- Disulfiram
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Medications for HIV treatment
- Clonidine
- Naltrexone (extended-release, injectable)
- Smoking not permitted
- Adults
- Young Adults
- Hospital inpatient treatment
- Hospital inpatient/24-hour hospital inpatient
- Hospital inpatient detoxification
- Mentoring/peer support
- Assistance with obtaining social services
- Self-help groups
- Housing services
- State Substance use treatment agency
- Hospital licensing authority
- State department of health
- Drug Enforcement Agency (DEA)
- State mental health department
- SAMHSA certification for opioid treatment program (OTP)
- The Joint Commission
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
Facility Operation (e.g., Private, Public)
External Source of Medications Used for Alcohol Use Disorder Treatment
Education and Counseling Services
Ancillary Services
Special Programs/Groups Offered
Facility Vaping Policy
Transitional Services
Type of Opioid Treatment
Payment/Insurance/Funding Accepted
Type of Care
Gender Accepted
Hospitals
Opioid Medications used in Treatment
Assessment/Pre-treatment
Language Services
Type of Alcohol Use Disorder Treatment
Testing
Treatment Approaches
Pharmacotherapies
Facility Smoking Policy
Age Groups Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Recovery Support Services
License/Certification/Accreditation
Detoxification (medical withdrawal) Services






